Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease

Inflammatory bowel disease (IBD), in particular Crohn’s disease refractory to conventional therapy, fistulizing Crohn’s disease and chronic active ulcerative colitis, generally respond well to anti-tumor necrosis factor (TNF) therapy. However, serious side effects do occur, necessitating careful mon...

Full description

Saved in:
Bibliographic Details
Main Authors: Hoentjen, Frank, van Bodegraven, Ad A
Format: Artigo
Language:Inglês
Published: The WJG Press and Baishideng 2009
Subjects:
Editorial
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2678575/
https://ncbi.nlm.nih.gov/pubmed/19418577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.2067
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items